in this controlled trial in 35 patients with lepromatous leprosy the therapeutic effects of adding rifampin 450 mg daily ( regimen a ) or 1200 mg once a month ( regimen b ) to a standard dapsone regimen of 50 mg daily were practically identical .
C0023348
lepromatous leprosy
C0010980
dapsone